TrialBMC palliative care2019

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).

Phillip Good et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.